Omid Seidizadeh: Advancing Genomic Insights into Bleeding Disorders at ISTH 2026
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, shared a post on LinkedIn:
“It was a pleasure to attend the International Society on Thrombosis and Haemostasis (ISTH) 2026 and meet many colleagues, collaborators, and scientists working across the fields of hemostasis and thrombosis.
During the meeting, I presented our data on whole-exome sequencing in patients with low von Willebrand factor and also had the opportunity to discuss our work on estimating the global and population prevalence of coagulation disorders using large-scale genomic databases at the ISTH SSC Omics session.
It was a great week of science, discussions, and new ideas, and I look forward to seeing how these conversations develop in the coming years.”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question